Socazolimab (ZKAB001), an anti-PD-L1 monoclonal antibody, demonstrates enduring safety and efficacy in treating recurrent or metastatic cervical cancer. Additionally, it shows promise for treating small cell lung cancer, esophageal squamous cell carcinom
CAS Number:
[2305043-30-3]
* VAT and and shipping costs not included. Errors and price changes excepted